Chapin Davis’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.57M Sell
25,860
-2,924
-10% -$681K 1.16% 24
2026
Q1
$7.04M Sell
28,784
-68
-0.2% -$15.8K 1.57% 20
2025
Q4
$5.97M Sell
28,852
-802
-3% -$159K 1.4% 18
2025
Q3
$5.5M Buy
29,654
+367
+1% +$62.9K 1.35% 17
2025
Q2
$4.47M Buy
29,287
+352
+1% +$54.1K 1.24% 24
2025
Q1
$4.8M Buy
28,935
+5,680
+24% +$889K 1.64% 14
2024
Q4
$3.77M Hold
23,255
1.23% 19
2024
Q3
$3.77M Buy
23,255
+1,262
+6% +$201K 1.22% 19
2024
Q2
$3.21M Buy
21,993
+644
+3% +$95.8K 1.1% 20
2024
Q1
$3.38M Sell
21,349
-1,127
-5% -$179K 1.23% 17
2023
Q4
$3.52M Buy
22,476
+692
+3% +$106K 1.48% 12
2023
Q3
$3.39M Buy
21,784
+819
+4% +$135K 1.62% 12
2023
Q2
$3.47M Buy
20,965
+974
+5% +$157K 1.65% 8
2023
Q1
$3.1M Buy
19,991
+498
+3% +$80.4K 1.6% 8
2022
Q4
$3.44M Buy
+19,493
New +$3.37M 2% 6

Other funds holding JNJ

Chapin Davis's JNJ Position: Q2 2026 in Review

Chapin Davis reduced its Johnson & Johnson (JNJ) stake by 10% in Q2 2026, selling an estimated $681K and leaving 25,860 shares worth $6.57M. The position accounts for 1.16% of the portfolio, ranked #24.

Chapin Davis first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.04M in Q1 2026. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Chapin Davis held 25,860 shares of Johnson & Johnson worth $6.57M as of Q2 2026.
  • Chapin Davis sold 2,924 Johnson & Johnson shares in Q2 2026, an estimated $681K.
  • Johnson & Johnson made up 1.16% of Chapin Davis's portfolio in Q2 2026, its #24 holding.
  • Chapin Davis first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Chapin Davis's Johnson & Johnson position peaked at $7.04M in Q1 2026.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.